ASCO Annual Report Names Significant Clinical Research Advances Of Past Year
Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial
Tykerb Plus Herceptin Better Than Monotherapy, Study Says
Bisphosphonates May Reduce Recurrent Breast Cancer
Study Finds High-Risk Women Reluctant To Take Tamoxifen
Cervical Cancer Screening Can Be Done Later, Less Often
No Benefit For Cetuximab In Early-Stage Colon Cancer
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- Narjust Duma named associate director of the Cancer Care Equity Program at DFCI, Harvard Medical School
- Robert Stone: City of Hope aims to transform cancer care nationally through new models, partnerships
- Biden commits to creating “ARPA-H” research body in visit to Ohio State
- Amy Reed, physician and patient who “moved mountains” to end widespread use of power morcellation, dies at 44
- The Cancer Letter gets a new website
You may have noticed that things are looking different around here - Abecma receives FDA approval for multiple myeloma
